Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.

Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Abstract Text:

    tsunehisa ohnoTsunehisa Ohno,shigeru hiranoShigeru Hirano,shin-ichi kanemaruShin-ichi Kanemaru,masaru yamashitaMasaru Yamashita,hiroo umedaHiroo Umeda,atsushi suehiroAtsushi Suehiro,yoshihiro tamuraYoshihiro Tamura,tatsuo nakamuraTatsuo Nakamura,juichi itoJuichi Ito,yasuhiko tabataYasuhiko Tabata,

    OBJECTIVES: Vocal fold scarring remains a therapeutic challenge. Previous studies have indicated that hepatocyte growth factor (HGF), a strong antifibrotic element, has therapeutic potential for restoring scarred vocal folds. To enhance the effect of HGF in vivo, we developed a novel drug delivery system (DDS) in which HGF is embedded in gelatin hydrogel and continuously released over a period of 2 weeks. In the present study we investigated the therapeutic efficacy of the HGF DDS on vocal fold scarring by using a canine model. METHODS: The vocal folds of 8 beagles were unilaterally scarred by stripping the entire layer of the lamina propria. The contralateral vocal folds were kept intact as normal controls. One month after the procedure, hydrogels (0.5 mL) containing 1 microg of HGF were injected into the scarred vocal folds of 4 dogs (HGF-treated group), whereas hydrogels containing saline solution were injected in the other 4 dogs (sham group). Histologic and vibratory examinations were completed for each group 6 months after the initial surgery. RESULTS: The excised larynx experiments showed significantly better vibration in terms of mucosal wave amplitude and glottal closure in the HGF-treated group compared to the sham group. Histologic evaluation of the vocal folds indicated remarkable reduction in collagen deposition and tissue contraction, with favorable restoration of hyaluronic acid and elastin in the HGF-treated group. CONCLUSIONS: The present findings suggest that the novel HGF DDS may provide favorable effects in restoring the vibratory properties of scarred vocal folds.

    Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Publishing Authors By Initials

    t ohnoT Ohno,s hiranoS Hirano,s kanemaruS Kanemaru,m yamashitaM Yamashita,h umedaH Umeda,a suehiroA Suehiro,y tamuraY Tamura,t nakamuraT Nakamura,j itoJ Ito,y tabataY Tabata,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Annals of otology, rhinology, and laryngology

    VOLUME: 116

    Page Numbers: 762-9

    Journal Abbreviation: Ann. Otol. Rhinol. Laryngol.

    ISSN: 0003-4894

    DAY: 29

    MONTH: Oct

    YEAR: 2007

    Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 407300

    Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.

    AFFILIATION: Dept of Otolaryngology-Head and Neck Surgery, Kyoto University Graduate School of Medicine, 54, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Otol Rhinol Laryngol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News